Mild-to-Moderate Facial Seborrheic Dermatitis After Systemic Antifungal Therapy Has Not Achieved Clearance

Clinical Scenario

Adult patient with mild-to-moderate seborrheic dermatitis of the face and/or body in whom systemic antifungal treatment was insufficient to achieve the required clinical response.

Prior Treatment — Inadequate Response

Systemic antifungal therapy (terbinafine or itraconazole) was the preceding treatment line. It did not achieve the goals of prompt reduction of seborrheic dermatitis symptoms and skin inflammation, nor complete clearing or marked improvement of lesions. This protocol addresses that unmet need.

Next-Step Approach

A light-based intervention is considered for diffuse or resistant seborrheic dermatitis, aiming for complete clearance or marked improvement.

Detailed scheduling, eligibility criteria, and the full structured regimen are in the complete protocol →

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.2147/CCID.S284671

However, limited clinical evidence supports the advantages of UVB phototherapy (Level C) in diffuse and resistant SD forms.

There is only one prospective, open-label clinical study showing narrow-band UVB phototherapy, three times weekly up to a maximum of 8 weeks, to be effective in improving severe SD, with complete clearance in 6 patients and marked improvement in 12.

View source ↗